Diopsys
Diopsys is a privately held medical device company founded in 1998, headquartered in Pine Brook, NJ, that develops ERG and VEP vision-testing equipment for healthcare providers, including those serving Medicare and Medicaid patients.
- Company typePrivate
- Founded1998
- HeadquartersPine Brook, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Diopsys does
Diopsys is a privately held medical device company founded in 1998 and headquartered in Pine Brook, New Jersey, that develops electroretinography (ERG) and visual evoked potential (VEP) vision-testing equipment for clinical diagnostic use. Its products are sold to healthcare providers — primarily ophthalmology and optometry practices — to objectively assess retinal and visual pathway function in patients, including those covered by Medicare and Medicaid.
The company operates with a small employee base of 11-50 people and distributes its devices through medical-device sales channels to healthcare providers. Its customer base is concentrated in clinical practices billing government healthcare programs, making federal reimbursement a critical component of its revenue model. Pricing, contract structures, and direct distribution details are not publicly disclosed.
Diopsys has been the subject of significant regulatory enforcement action. According to the available data, in March 2026 the company agreed to a $14.25 million settlement with the U.S. Department of Justice for allegedly causing providers to bill Medicare and Medicaid for medically unnecessary vision tests using an uncleared device. The settlement is the single most material documented event in the company's history and frames any investment assessment around regulatory risk tied to device clearance and federal program billing compliance.
Diopsys firmographics
Firmographics- Name
- Diopsys
- Website
- https://diopsys.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Diopsys is a privately held medical device company founded in 1998, headquartered in Pine Brook, NJ, that develops ERG and VEP vision-testing equipment for healthcare providers, including those serving Medicare and Medicaid patients.
- Ownership category
- akta.pro rank
Diopsys industry classification
Industry- Product category
- Ophthalmic Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
- akta.pro secondary industry
- Comprehensive Eye Exams & Vision Care (HLAKAKAA)
Keywords
Where Diopsys is headquartered
LocationHeadquarters
- HQ city
- Pine Brook
- HQ country
- United States
- HQ region
- North America
Markets served
Diopsys business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Diopsys product offering
Product offeringCore offering
Diopsys designs, manufactures, and sells medical devices used by healthcare providers to perform electroretinography (ERG) and visual evoked potential (VEP) vision tests for diagnostic purposes. The company's products are deployed in clinical settings to support patient diagnosis of vision disorders.
Product overview
Diopsys offers vision testing devices/equipment. Based on enforcement-related news sources, Diopsys produces medical devices used for vision testing, with its devices being the subject of a DOJ settlement related to Medicare and Medicaid billing for vision tests.
Differentiator
Problem solved
Functional benefit
Products and services
- ERG (Electroretinography) Vision Testing Device Medical device used by healthcare providers to perform electroretinography vision tests for diagnostic evaluation of retinal function in patients.
- VEP (Visual Evoked Potential) Vision Testing Device Medical device used by healthcare providers to perform visual evoked potential tests for diagnostic evaluation of the visual pathway in patients.
Companies that use Diopsys
Customer profileSegments2 records
Ideal customer profiles2 records
Diopsys technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Diopsys partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Diopsys competitors and assessment
Company assessmentDirect peers
- LKC Technologies: LKC Technologies produces electrophysiology devices including ERG and visual testing equipment, and is one of the closest functional peers to Diopsys in vision electrophysiology instrumentation.
- Diagnosys LLC: Diagnosys designs and manufactures clinical electroretinography (ERG) and visual evoked potential (VEP) systems, directly competing with Diopsys in the electrophysiology-based ophthalmic diagnostic segment.
Emerging players
- Konan Medical: Konan Medical specializes in objective functional vision testing (e.g., pupillometry and perimetry), making it a relevant emerging/specialty peer adjacent to Diopsys' electrophysiology focus.
- Natus Medical Incorporated: Natus Medical manufactures neurodiagnostic and electrophysiology equipment used in vision and neurology testing, providing adjacent peer comparison on ERG/VEP underlying technology.
Broad incumbents
- Haag-Streit Group: Haag-Streit offers ophthalmic diagnostic equipment and perimetry systems used in the same clinical vision-testing environments as Diopsys' ERG/VEP products.
- Heidelberg Engineering: Heidelberg Engineering is an established ophthalmic diagnostic imaging and spectroscopy platform company whose portfolio overlaps with Diopsys' clinical vision diagnostics customers and sales channels.
- Carl Zeiss Meditec: Carl Zeiss Meditec offers a broad portfolio of ophthalmic diagnostic and surgical equipment, including imaging and functional testing, competing in the same provider purchasing workflows as Diopsys.
- Topcon Healthcare: Topcon Healthcare markets ophthalmic and optometric diagnostic instruments, including imaging and functional testing devices, sharing Diopsys' optometry and ophthalmology end-user base.
- Nidek Co., Ltd. Nidek manufactures a broad range of ophthalmic diagnostic devices and shares significant overlap with Diopsys in eye-care provider equipment sales channels.
- Reichert Technologies (AMETEK): Reichert Technologies manufactures ophthalmic diagnostic instruments including tonometers and refractors, sharing the same vision-care provider channel as Diopsys.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights3 records
Customer concentration
Diopsys social profiles
Digital presenceDiopsys financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diopsys leadership team
Management profileNumber of profiles
Profiles1 record
Diopsys funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diopsys M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diopsys
What does Diopsys do?
Diopsys designs, manufactures, and sells medical devices used by healthcare providers to perform electroretinography (ERG) and visual evoked potential (VEP) vision tests for diagnostic purposes. The company's products are deployed in clinical settings to support patient diagnosis of vision disorders.
Is Diopsys a public or private company?
Diopsys is a private company. It is classified as unknown and is currently operating.
When was Diopsys founded?
Diopsys was founded in 1998. It employs 11 to 50 people.
Where is Diopsys based?
Diopsys is headquartered in Pine Brook, United States, in the North America region.
Who are Diopsys's main competitors?
Direct peers on record are LKC Technologies and Diagnosys LLC. Emerging players are Konan Medical and Natus Medical Incorporated. Broad incumbents are Haag-Streit Group, Heidelberg Engineering, Carl Zeiss Meditec, Topcon Healthcare, Nidek Co., Ltd. and Reichert Technologies (AMETEK).
Does Diopsys have an API?
No public API is recorded for Diopsys.
What industry is Diopsys in?
Diopsys's product category is Ophthalmic Diagnostic Devices. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLAKAKAA, Comprehensive Eye Exams & Vision Care. Its NAICS code is 334510 and its SIC code is 3845.